AAAAAA

   
Results: 1-20 |
Results: 20
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis
Authors: Bos, R Zhong, H Hanrahan, CF Mommers, ECM Semenza, GL Pinedo, HM Abeloff, MD Simons, JW van Diest, PJ van der Wall, E
Citation: R. Bos et al., Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis, J NAT CANC, 93(4), 2001, pp. 309-314
Evaluation of passenger rail vehicle crashworthiness
Authors: Kirkpatrick, SW Schroeder, M Simons, JW
Citation: Sw. Kirkpatrick et al., Evaluation of passenger rail vehicle crashworthiness, INT J CRASH, 6(1), 2001, pp. 95-106
Activation of hypoxia-inducible factor 1 alpha by oxygen independent pathways
Authors: Zhong, H Simons, JW
Citation: H. Zhong et Jw. Simons, Activation of hypoxia-inducible factor 1 alpha by oxygen independent pathways, EXP ONCOL, 23(2), 2001, pp. 88-96
Angiogenesis and prostate cancer: Identification of a molecular progression switch
Authors: Huss, WJ Hanrahan, CF Barrios, RJ Simons, JW Greenberg, NM
Citation: Wj. Huss et al., Angiogenesis and prostate cancer: Identification of a molecular progression switch, CANCER RES, 61(6), 2001, pp. 2736-2743
A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
Authors: DeWeese, TL van der Poel, H Li, SD Mikhak, B Drew, R Goemann, M Hamper, U DeJong, R Detorie, N Rodriguez, R Haulk, T DeMarzo, AM Piantadosi, S Yu, DC Chen, Y Henderson, DR Carducci, MA Nelson, WG Simons, JW
Citation: Tl. Deweese et al., A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy, CANCER RES, 61(20), 2001, pp. 7464-7472
Hypoxia-inducible factor 1 alpha and 1 beta proteins share common signaling pathways in human prostate cancer cells
Authors: Zhong, H Hanrahan, C van der Poel, H Simons, JW
Citation: H. Zhong et al., Hypoxia-inducible factor 1 alpha and 1 beta proteins share common signaling pathways in human prostate cancer cells, BIOC BIOP R, 284(2), 2001, pp. 352-356
Human gene therapy for urological oncology
Authors: Ferrer, F Simons, JW Rodriguez, R
Citation: F. Ferrer et al., Human gene therapy for urological oncology, CONT CANC R, 2001, pp. 483-497
Molecular events implicated in brain tumor angiogenesis and invasion
Authors: Zagzag, D Friedlander, DR Margolis, B Grumet, M Semenza, GL Zhong, H Simons, JW Holash, J Wiegand, SJ Yancopoulos, GD
Citation: D. Zagzag et al., Molecular events implicated in brain tumor angiogenesis and invasion, PED NEUROS, 33(1), 2000, pp. 49-55
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor
Authors: Karth, J Ferrer, FA Perlman, E Hanrahan, C Simons, JW Gearhart, JP Rodriguez, R
Citation: J. Karth et al., Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor, J PED SURG, 35(12), 2000, pp. 1749-1753
Modulation of hypoxia-inducible factor 1 alpha expression by the epidermalgrowth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in humanprostate cancer cells: Implications for tumor angiogenesis and therapeutics
Authors: Zhong, H Chiles, K Feldser, D Laughner, E Hanrahan, C Georgescu, MM Simons, JW Semenza, GL
Citation: H. Zhong et al., Modulation of hypoxia-inducible factor 1 alpha expression by the epidermalgrowth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in humanprostate cancer cells: Implications for tumor angiogenesis and therapeutics, CANCER RES, 60(6), 2000, pp. 1541-1545
Expression of hypoxia-inducible factor 1 alpha in brain tumors - Association with angiogenesis, invasion, and progression
Authors: Zagzag, D Zhong, H Scalzitti, JM Laughner, E Simons, JW Semenza, GL
Citation: D. Zagzag et al., Expression of hypoxia-inducible factor 1 alpha in brain tumors - Association with angiogenesis, invasion, and progression, CANCER, 88(11), 2000, pp. 2606-2618
Characterization of the role of IL-6 in the progression of prostate cancer
Authors: Chung, TDK Yu, JQJ Spiotto, MT Bartkowski, M Simons, JW
Citation: Tdk. Chung et al., Characterization of the role of IL-6 in the progression of prostate cancer, PROSTATE, 38(3), 1999, pp. 199-207
Urologic applications of gene therapy
Authors: Rodriguez, R Simons, JW
Citation: R. Rodriguez et Jw. Simons, Urologic applications of gene therapy, UROLOGY, 54(3), 1999, pp. 401-406
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma
Authors: Carducci, MA Piantadosi, S Pound, CR Epstein, JI Simons, JW Marshall, FF Partin, AW
Citation: Ma. Carducci et al., Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma, UROLOGY, 53(1), 1999, pp. 44-49
Overexpression of hypoxia-inducible factor 1 alpha in common human cancersand their metastases
Authors: Zhong, H De Marzo, AM Laughner, E Lim, M Hilton, DA Zagzag, D Buechler, P Isaacs, WB Semenza, GL Simons, JW
Citation: H. Zhong et al., Overexpression of hypoxia-inducible factor 1 alpha in common human cancersand their metastases, CANCER RES, 59(22), 1999, pp. 5830-5835
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
Authors: Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Lim, M Weber, CE Baccala, AA Goemann, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF Nelson, WG
Citation: Jw. Simons et al., Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer, CANCER RES, 59(20), 1999, pp. 5160-5168
Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia
Authors: Zhong, H Simons, JW
Citation: H. Zhong et Jw. Simons, Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia, BIOC BIOP R, 259(3), 1999, pp. 523-526
Ex vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
Authors: Simons, JW Mikhak, B
Citation: Jw. Simons et B. Mikhak, Ex vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology, SEMIN ONCOL, 25(6), 1998, pp. 661-676
Increased expression of hypoxia inducible factor-1 alpha in rat and human prostate cancer
Authors: Zhong, H Agani, F Baccala, AA Laughner, E Rioseco-Camacho, N Isaacs, WB Simons, JW Semenza, GL
Citation: H. Zhong et al., Increased expression of hypoxia inducible factor-1 alpha in rat and human prostate cancer, CANCER RES, 58(23), 1998, pp. 5280-5284
Risultati: 1-20 |